These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27145235)

  • 1. Proximal location in extremity long bones is a poor prognostic factor for osteosarcoma: A retrospective cohort study of 153 patients.
    Cates JM; Schoenecker JG
    Acta Oncol; 2016 Aug; 55(8):1036-9. PubMed ID: 27145235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential presentations, clinical courses, and survivals of osteosarcomas of the proximal humerus over other extremity locations.
    Cho WH; Song WS; Jeon DG; Kong CB; Kim MS; Lee JA; Yoo JY; Kim JD; Lee SY
    Ann Surg Oncol; 2010 Mar; 17(3):702-8. PubMed ID: 19921336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
    J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcoma.
    Jeon DG; Song WS; Cho WH; Kong CB; Cho SH
    Clin Orthop Relat Res; 2014 Jun; 472(6):1911-20. PubMed ID: 24574120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma.
    Kim MS; Lee SY; Lee TR; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
    Ann Oncol; 2009 May; 20(5):955-60. PubMed ID: 19153123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting Surgical Resection Margin Status for Osteosarcoma: Comparison of the AJCC, MSTS, and Margin Distance Methods.
    Cates JM
    Am J Surg Pathol; 2017 May; 41(5):633-642. PubMed ID: 28125453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial tumor size predicts histologic response and survival in localized osteosarcoma patients.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
    J Surg Oncol; 2008 Apr; 97(5):456-61. PubMed ID: 18270971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous necrosis and additional tumor necrosis induced by preoperative chemotherapy for osteosarcoma: a case-control study.
    Song WS; Jeon DG; Cho WH; Kong CB; Cho SH; Lee SY; Lee SY
    J Orthop Sci; 2015 Jan; 20(1):174-9. PubMed ID: 25355661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post operative infection and increased survival in osteosarcoma patients: are they associated?
    Jeys LM; Grimer RJ; Carter SR; Tillman RM; Abudu A
    Ann Surg Oncol; 2007 Oct; 14(10):2887-95. PubMed ID: 17653803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
    Lin L; Deng S; Zhang F; Liang Y; Huang Z
    World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
    Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
    BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
    Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
    Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.
    Bielack SS; Kempf-Bielack B; Delling G; Exner GU; Flege S; Helmke K; Kotz R; Salzer-Kuntschik M; Werner M; Winkelmann W; Zoubek A; Jürgens H; Winkler K
    J Clin Oncol; 2002 Feb; 20(3):776-90. PubMed ID: 11821461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
    Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
    Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic fracture does not influence local recurrence and survival in high-grade extremity osteosarcoma with adequate surgical margins.
    Xie L; Guo W; Li Y; Ji T; Sun X
    J Surg Oncol; 2012 Dec; 106(7):820-5. PubMed ID: 22740310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvis and extremity osteosarcoma with similar tumor volume have an equivalent survival.
    Song WS; Cho WH; Jeon DG; Kong CB; Kim MS; Lee JA; Eid AS; Kim JD; Lee SY
    J Surg Oncol; 2010 Jun; 101(7):611-7. PubMed ID: 20461769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Impact of Proximal
    Berner K; Bruland ØS
    Anticancer Res; 2019 May; 39(5):2459-2466. PubMed ID: 31092440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neoadjuvant chemotherapy for osteosarcoma].
    Guo W; Yang RL; Tang XD; Tang S; Li DS; Yang Y
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1186-90. PubMed ID: 15387981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
    Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
    Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials.
    Whelan JS; Jinks RC; McTiernan A; Sydes MR; Hook JM; Trani L; Uscinska B; Bramwell V; Lewis IJ; Nooij MA; van Glabbeke M; Grimer RJ; Hogendoorn PC; Taminiau AH; Gelderblom H
    Ann Oncol; 2012 Jun; 23(6):1607-16. PubMed ID: 22015453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.